Jiannong Liu

Jiannong Liu

Auto-generated profile, based on publicly available information

Jiannong Liu

Chronic Disease Research Group, Minneapolis, MN

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Kidney International
Verified
Journal Article
Closed access
JLJiannong Liu
Jiannong Liu
ZHZhi Huang
Zhi Huang
DGDavid T. Gilbertson
David T. Gilbertson
RFRobert N. Foley
Robert N. Foley
ACAllan J. Collins
Allan J. Collins

1 February 2012 in Kidney International
Verified
Journal Article
Closed access
JLJiannong Liu
Jiannong Liu
EWEric D. Weinhandl
Eric D. Weinhandl
DGDavid T. Gilbertson
David T. Gilbertson
ACAllan J. Collins
Allan J. Collins
WSWendy StPeter
Wendy StPeter

1 December 2003
Verified
Journal Article
Closed access
ACAllan J Collins
Allan J Collins
BKBertram Kasiske
Bertram Kasiske
CHCharles Herzog
Charles Herzog
SCShu-Cheng Chen
Shu-Cheng Chen
SESusan Everson
Susan Everson
LALawrence Agodoa
Lawrence Agodoa

26 June 2008 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
RFRobert N Foley
Robert N Foley
QFQiao Fan
Qiao Fan
JLJiannong Liu
Jiannong Liu
DGDavid T Gilbertson
David T Gilbertson
EWEric D Weinhandl
Eric D Weinhandl
ACAllan J Collins
Allan J Collins
Concern lingers that dialysis therapy at for-profit (versus not-for-profit) hemodialysis facilities in the United States may be associated with higher mortality, even though 4 of every 5 contemporary dialysis patients receive therapy in such a setting. Our primary objective was to compare the mortality hazards of patients initiating hemodialysis at for-profit and not-for-profit centers in the United States between 1998 and 2003. For-profit status of dialysis facilities was determined after subjects received 6 months of dialysis therapy, and mean follow-up was 1.7 years. Of the study population (N = 205,076), 79.9% were dialyzed in for-profit facilities after 6 months of dialysis therapy. Dialysis at for-profit facilities was associated with higher urea reduction ratios, hemoglobin levels (including levels above 12 and 13 g/dL [120 and 130 g/L]), epoetin doses, and use of intravenous iron, and less use of blood transfusions and lower proportions of patients on the transplant waiting-list (P < 0.05). Patients dialyzed at for-profit and at not-for-profit facilities had similar mortality risks (adjusted hazards ratio 1.02, 95% CI 0.99–1.06, P = 0.143). While hemodialysis treatment at for-profit and not-for-profit dialysis facilities is associated with different patterns of clinical benchmark achievement, mortality rates are similar.

1 April 2006 in Kidney International
Verified
Journal Article
Closed access
PDF file
JLJ. Liu
J. Liu
TLT.A. Louis
T.A. Louis
WPW. Pan
W. Pan
JMJ.Z. Ma
J.Z. Ma
ACA.J. Collins
A.J. Collins

1 December 2000 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
ACAllan J. Collins
Allan J. Collins
BKBertram Kasiske
Bertram Kasiske
SCShu-Cheng Chen
Shu-Cheng Chen
SESusan Everson
Susan Everson
ECEdward Constantini
Edward Constantini
LALawrence Agodoa
Lawrence Agodoa